Japan’s reimbursement system evaluates imported medical devices similarly to domestic ones, requiring regulatory approval from PMDA & submission to MHLW for reimbursement. Imported devices must demonstrate safety, efficacy, & cost-effectiveness. Local agents often assist with compliance, market entry, & documentation. Pricing may consider foreign market prices but adapts to Japan’s NHI system standards.
